[Augmentation of killer activity in regional lymph nodes in gastric cancer by intratumoral injection of immunopotentiators].
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000627:therapeutic use*; D003602:Cytotoxicity, Immunologic; D005260:Female; D006801:Humans; D007267:Injections; D007376:Interleukin-2 / Q000627:therapeutic use; D007694:Killer Cells, Natural / Q000276:immunology*; D008198:Lymph Nodes / Q000276:immunology*; D008297:Male; D010844:Picibanil / Q000627:therapeutic use; D011509:Proteoglycans / Q000627:therapeutic use; D013270:Stomach; D013274:Stomach Neoplasms / Q000276:immunology* / Q000628:therapy
D000276:Adjuvants, Immunologic; D007376:Interleukin-2; D011509:Proteoglycans; D010844:Picibanil; C010770:polysaccharide-K